Asthma patients' self-reported behaviours toward inhaled corticosteroids.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 19398316)

Published in Respir Med on April 24, 2009

Authors

Laurent Laforest1, Abdelkader El Hasnaoui, Céline Pribil, Cécile Ritleng, Liesl M Osman, Marie-Sophie Schwalm, Philippe Le Jeunne, Eric Van Ganse

Author Affiliations

1: CHU Lyon, Unité de Pharmacoépidémiologie, Service de Neurologie, Hôpital Pierre Wertheimer, 59 Boulevard Pinel, Bron, France.

Articles by these authors

Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection. Am J Gastroenterol (2005) 2.62

Risk factors for adverse events in analgesic drug users: results from the PAIN study. Pharmacoepidemiol Drug Saf (2003) 1.47

Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs. Arch Cardiovasc Dis (2009) 1.40

Distribution of COPD-related symptoms in the Middle East and North Africa: results of the BREATHE study. Respir Med (2012) 1.34

Prevalence and description of chronic daily headache in the general population in France. Pain (2003) 1.33

GP discussion of prognosis with patients with severe chronic obstructive pulmonary disease: a qualitative study. Br J Gen Pract (2004) 1.28

Smoking habits in the Middle East and North Africa: results of the BREATHE study. Respir Med (2012) 1.27

Allergic rhinitis and its consequences on quality of sleep: An unexplored area. Arch Intern Med (2006) 1.23

Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses. Qual Life Res (2008) 1.18

Ongoing pharmaceutical reforms in France: implications for key stakeholder groups. Appl Health Econ Health Policy (2010) 1.17

Quality of life during pollen season in patients with seasonal allergic rhinitis with or without asthma. Int Arch Allergy Immunol (2005) 1.03

Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterol Clin Biol (2006) 1.03

Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: the BREATHE study. Respir Med (2012) 0.98

Attitudes and beliefs about COPD: data from the BREATHE study. Respir Med (2012) 0.98

Prevalence of asthma in North Africa: the Asthma Insights and Reality in the Maghreb (AIRMAG) study. Respir Med (2009) 0.98

Control of asthma in children: still unacceptable? A French cross-sectional study. Respir Med (2009) 0.96

Management of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study. Respir Med (2012) 0.95

Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study. BMC Pulm Med (2014) 0.95

The burden of chronic obstructive pulmonary disease in the Middle East and North Africa: results of the BREATHE study. Respir Med (2012) 0.95

Association between asthma control in children and loss of workdays by caregivers. Ann Allergy Asthma Immunol (2004) 0.94

Risk of malaria among French adult travellers. Travel Med Infect Dis (2005) 0.94

Control of asthma in the Maghreb: results of the AIRMAG study. Respir Med (2009) 0.94

Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study. Pharmacoeconomics (2004) 0.92

Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroenterol Clin Biol (2004) 0.91

Wheezy bronchitis in childhood: a distinct clinical entity with lifelong significance? Chest (2003) 0.90

Influence of patients' characteristics and disease management on asthma control. J Allergy Clin Immunol (2006) 0.90

Discrepancies between patient-reported outcomes and clinician-reported outcomes in chronic venous disease, irritable bowel syndrome, and peripheral arterial occlusive disease. Value Health (2006) 0.90

A generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer. Int J Public Health (2010) 0.90

Results of a national asthma campaign survey of primary care in Scotland. Int J Qual Health Care (2005) 0.89

[INSTANT: national survey of allergic rhinitis in a French adult population based-sample]. Presse Med (2009) 0.88

Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria. Gastroenterol Clin Biol (2002) 0.88

A retrospective, case-control study of acyclovir resistance in herpes simplex virus. Clin Infect Dis (2005) 0.88

Correlates of adherence to respiratory drugs in COPD patients. Prim Care Respir J (2010) 0.88

Nasal polyposis in France: impact on sleep and quality of life. J Laryngol Otol (2005) 0.88

Psychometric validation of the French version of the quality of life in epilepsy inventory (QOLIE-31): comparison with a generic health-related quality of life questionnaire. Epileptic Disord (2004) 0.87

Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords. Ann Neurol (2010) 0.87

Health status of professional divers and offshore oil industry workers. Occup Med (Lond) (2007) 0.86

True device compliance: the need to consider both competence and contrivance. Respir Med (2005) 0.86

How appropriate is asthma therapy in general practice? Fundam Clin Pharmacol (2005) 0.85

Evolution of migraine after a 10-year follow-up. Headache (2005) 0.85

Asthmatic patients' poor awareness of inadequate disease control: a pharmacy-based survey. Ann Allergy Asthma Immunol (2007) 0.85

Changes in osteoarthritis management by general practitioners in the COX2-inhibitor era-concomitant gastroprotective therapy. Joint Bone Spine (2004) 0.85

Evidence on the global measurement model of the Minnesota Living with Heart Failure Questionnaire. Qual Life Res (2013) 0.85

A survey on the prevalence of orofacial herpes in France: the INSTANT Study. J Am Acad Dermatol (2006) 0.84

Characterisation of patients with postmenopausal osteoporosis in French primary healthcare. Drugs Aging (2007) 0.84

Psychometric evaluation of the COPD assessment test: data from the BREATHE study in the Middle East and North Africa region. Respir Med (2012) 0.84

Relative exposure to controller therapy and asthma exacerbations: a validation study in community pharmacies. Pharmacoepidemiol Drug Saf (2014) 0.84

Factors associated with regular cervical cancer screening. Int J Gynaecol Obstet (2008) 0.84

Epidemiology of genital herpes simplex virus infections in a community-based sample in France: results of the HERPIMAX study. Sex Transm Dis (2005) 0.83

Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapy. Atherosclerosis (2008) 0.83

Asthma drug ratios and exacerbations: claims data from universal health coverage systems. Eur Respir J (2014) 0.83

Paediatric asthma in North Africa: the Asthma Insights and Reality in the Maghreb (AIRMAG) study. Respir Med (2009) 0.83

Diagnostic indicators of restless legs syndrome in primary care consultations: the DESYR study. Mov Disord (2007) 0.82

Underutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugs. Dig Liver Dis (2010) 0.82

Minor illness education for parents of young children. J Adv Nurs (2003) 0.81

Dispensing of antibiotics, antitussives and mucolytics to asthma patients: a pharmacy-based observational survey. Respir Med (2007) 0.81

Impact of headache on quality of life in a general population survey in France (GRIM2000 Study). Headache (2004) 0.81

Correlates of quality of life in patients with asthma. Ann Allergy Asthma Immunol (2005) 0.81

Impact of innate and environmental factors on wheezing persistence during childhood. J Asthma (2010) 0.80

Intrapatient variability of migraine attacks: stability analysis of the MIGSEV scale. Headache (2008) 0.80

Annual review of patients with sleep apnea/hypopnea syndrome--a pragmatic randomised trial of nurse home visit versus consultant clinic review. Sleep Med (2004) 0.80

Factors associated with early adherence to tiotropium in chronic obstructive pulmonary disease. Chron Respir Dis (2012) 0.80

Primary care physicians' behaviors towards risk of iatrogenesis in elderly patients. Eur J Clin Pharmacol (2006) 0.79

[General practitioners' management of gastroesophageal reflux in France in 2005: a pharmacoeconomic study]. Presse Med (2008) 0.79

Mixed dyslipidemias in primary care patients in France. Vasc Health Risk Manag (2012) 0.79

Objective neuropsychological test performance of professional divers reporting a subjective complaint of "forgetfulness or loss of concentration". Scand J Work Environ Health (2006) 0.79

Asthma patients' perception of their ability to influence disease control and management. Ann Allergy Asthma Immunol (2009) 0.79

Evaluation of a diagnostic questionnaire for nasal polyposis: an observational, cross-sectional study. Rhinology (2004) 0.78

Influence of sociodemographic factors on quality of life during pollen season in seasonal allergic rhinitis patients. Ann Allergy Asthma Immunol (2005) 0.78

Long-term treatment acceptance: what is it, and how can it be assessed? Patient (2012) 0.78

The safety of drugs for OTC use: what evidence is required for an NSAID switch? Pharmacoepidemiol Drug Saf (2002) 0.78

[Economic aspects of severe asthma]. Presse Med (2007) 0.78

Factors influencing dispensing of psychotropic medications to patients with asthma: a community pharmacy-based survey. Ann Allergy Asthma Immunol (2008) 0.77

Correlates of quality of life of pre-obese and obese patients: a pharmacy-based cross-sectional survey. BMC Public Health (2009) 0.75

Recurrent Wheezing in Infants: A Population-Based Study. Medicine (Baltimore) (2016) 0.75

Asthma and allergy medication use and costs among pediatric primary care patients on asthma controller therapy. Pediatr Allergy Immunol (2006) 0.75

[Difficulties in the assessment of dyspnea and respiratory function in general practice]. Presse Med (2009) 0.75

[The Vigimig study of naratriptan use in general practice]. Presse Med (2007) 0.75

[Prevention of human papillomavirus (HPV)-induced infections: access of adolescent girls to health care. A population-based, cross-sectional observational study]. Presse Med (2007) 0.75

Improvement in quality of life after initiation of lamotrigine therapy in patients with epilepsy in a naturalistic treatment setting. Seizure (2007) 0.75

Illness perception of migraineurs from the general population. Psychol Health (2012) 0.75